Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V H Fingar

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
International Journal of Radiation Biology|July 1, 1991
Mechanistic studies of PDT-induced vascular damage: evidence that eicosanoids mediate this processV H Fingar, T J Wieman, K W Doak
Journal of Surgical Oncology|August 29, 1998
Photodynamic therapy for palliation of chest wall recurrence in patients with breast cancerS W Taber, V H Fingar, T J Wieman
Photochemistry and Photobiology|October 24, 1997
The effects of thrombocytopenia on vessel stasis and macromolecular leakage after photodynamic therapy using photofrinV H Fingar, T J Wieman, P S Haydon
Photochemistry and Photobiology|May 1, 1987
Drug and light dose dependence of photodynamic therapy: a study of tumor cell clonogenicity and histologic changesV H Fingar, W R Potter, B W Henderson
Surgery|October 16, 1999
The treatment of malignant endobronchial obstruction with laser ablationS W Taber, W C Buschemeyer, V H Fingar, et al.
Photochemistry and Photobiology|September 1, 1993
The effects of thromboxane inhibitors on the microvascular and tumor response to photodynamic therapyV H Fingar, K A Siegel, T J Wieman, et al.
Methods in Enzymology|January 1, 1997
Expression of chemokine receptors by endothelial cells: detection by intravital microscopy using chemokine-coated fluorescent microspheresV H Fingar, H H Guo, Z H Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical studyS W Taber, V H Fingar, C T Coots, et al.
Cancer Research|October 15, 1994
Effects of photodynamic therapy using mono-L-aspartyl chlorin e6 on vessel constriction, vessel leakage, and tumor responseK S McMahon, T J Wieman, P H Moore, et al.
The Journal of Surgical Research|November 1, 1992
Implications of a pre-existing tumor hypoxic fraction on photodynamic therapyV H Fingar, T J Wieman, Y J Park, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
International Journal of Radiation Biology|July 1, 1991
Mechanistic studies of PDT-induced vascular damage: evidence that eicosanoids mediate this processV H Fingar, T J Wieman, K W Doak
Journal of Surgical Oncology|August 29, 1998
Photodynamic therapy for palliation of chest wall recurrence in patients with breast cancerS W Taber, V H Fingar, T J Wieman
Photochemistry and Photobiology|October 24, 1997
The effects of thrombocytopenia on vessel stasis and macromolecular leakage after photodynamic therapy using photofrinV H Fingar, T J Wieman, P S Haydon
Photochemistry and Photobiology|May 1, 1987
Drug and light dose dependence of photodynamic therapy: a study of tumor cell clonogenicity and histologic changesV H Fingar, W R Potter, B W Henderson
Surgery|October 16, 1999
The treatment of malignant endobronchial obstruction with laser ablationS W Taber, W C Buschemeyer, V H Fingar, et al.
Photochemistry and Photobiology|September 1, 1993
The effects of thromboxane inhibitors on the microvascular and tumor response to photodynamic therapyV H Fingar, K A Siegel, T J Wieman, et al.
Methods in Enzymology|January 1, 1997
Expression of chemokine receptors by endothelial cells: detection by intravital microscopy using chemokine-coated fluorescent microspheresV H Fingar, H H Guo, Z H Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical studyS W Taber, V H Fingar, C T Coots, et al.
Cancer Research|October 15, 1994
Effects of photodynamic therapy using mono-L-aspartyl chlorin e6 on vessel constriction, vessel leakage, and tumor responseK S McMahon, T J Wieman, P H Moore, et al.
The Journal of Surgical Research|November 1, 1992
Implications of a pre-existing tumor hypoxic fraction on photodynamic therapyV H Fingar, T J Wieman, Y J Park, et al.
Pageof 4